New Two-Pronged attack on bladder urgency in women
NCT ID NCT07429734
Summary
This study aims to see if combining two existing drugs, solifenacin and gabapentin, is more effective and safe for treating overactive bladder in women than using solifenacin alone. It will involve 60 women with bothersome bladder symptoms. Researchers hope the combination targets both the muscle and nerve signals involved in urgency, providing better symptom relief.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERACTIVE BLADDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Urology and Nephrology center - Mansoura University
Al Mansurah, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.